MANGOCEUTICALS, INC. Reports Unregistered Equity Sale
Ticker: MGRX · Form: 8-K · Filed: Apr 8, 2025 · CIK: 1938046
| Field | Detail |
|---|---|
| Company | Mangoceuticals, INC. (MGRX) |
| Form Type | 8-K |
| Filed Date | Apr 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: unregistered-sale, equity-securities
TL;DR
MANGOCEUTICALS sold unregistered equity, details TBD.
AI Summary
On March 28, 2025, MANGOCEUTICALS, INC. reported an unregistered sale of equity securities. The filing does not disclose specific details regarding the number of securities sold, the price, or the parties involved in this transaction.
Why It Matters
This filing indicates a potential dilution of existing shares or a new funding round, which could impact the company's financial structure and stock value.
Risk Assessment
Risk Level: medium — Unregistered sales can sometimes signal financial distress or a need for capital, and lack of detail raises questions about the terms and impact.
Key Players & Entities
- MANGOCEUTICALS, INC. (company) — Registrant
- March 28, 2025 (date) — Date of Earliest Event Reported
- Texas (location) — State of Incorporation
- Dallas (location) — Principal Executive Offices City
- 75248 (postal_code) — Principal Executive Offices Zip Code
FAQ
What type of equity securities were sold?
The filing does not specify the type of equity securities sold.
How many securities were sold in this unregistered offering?
The filing does not disclose the number of securities sold.
What was the price per security for this unregistered sale?
The filing does not provide information on the price per security.
Who were the purchasers of these unregistered equity securities?
The filing does not identify the purchasers of the unregistered equity securities.
What is the purpose of this unregistered sale of equity securities?
The filing does not state the specific purpose for the unregistered sale of equity securities.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 8, 2025 regarding MANGOCEUTICALS, INC. (MGRX).